Laraway Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.19M Sell
2,381
-164
-6% -$166K 1.54% 15
2025
Q4
$2.74M Sell
2,545
-135
-5% -$129K 1.78% 14
2025
Q3
$2.04M Hold
2,680
1.4% 18
2025
Q2
$2.09M Sell
2,680
-114
-4% -$88.6K 1.58% 17
2025
Q1
$2.31M Sell
2,794
-9,175
-77% -$7.63M 1.83% 13
2024
Q4
$2.87M Buy
11,969
+9,097
+317% +$7.53M 2.21% 13
2024
Q3
$2.54M Sell
2,872
-23
-0.8% -$20.7K 2.03% 13
2024
Q2
$2.62M Buy
2,895
+7
+0.2% +$5.6K 2.24% 11
2024
Q1
$2.25M Sell
2,888
-9
-0.3% -$6.41K 1.98% 14
2023
Q4
$1.69M Sell
2,897
-104
-3% -$60.7K 1.6% 17
2023
Q3
$1.61M Sell
3,001
-73
-2% -$37.6K 1.68% 17
2023
Q2
$1.44M Sell
3,074
-315
-9% -$132K 1.43% 17
2023
Q1
$1.16M Sell
3,389
-199
-6% -$67.1K 1.18% 22
2022
Q4
$1.31M Sell
3,588
-92
-3% -$32.6K 1.37% 21
2022
Q3
$1.19M Sell
3,680
-20
-0.5% -$6.34K 1.33% 22
2022
Q2
$1.2M Sell
3,700
-230
-6% -$69K 1.27% 21
2022
Q1
$1.13M Hold
3,930
1.03% 30
2021
Q4
$1.09M Buy
+3,930
New +$996K 0.97% 33

Other funds holding LLY

Laraway Financial Advisors's LLY Position: Q1 2026 in Review

Laraway Financial Advisors reduced its Eli Lilly (LLY) stake by 6.4% in Q1 2026, selling an estimated $166K and leaving 2,381 shares worth $2.19M. The position accounts for 1.54% of the portfolio, ranked #15.

Laraway Financial Advisors first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.87M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Laraway Financial Advisors held 2,381 shares of Eli Lilly worth $2.19M as of Q1 2026.
  • Laraway Financial Advisors sold 164 Eli Lilly shares in Q1 2026, an estimated $166K.
  • Eli Lilly made up 1.54% of Laraway Financial Advisors's portfolio in Q1 2026, its #15 holding.
  • Laraway Financial Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Laraway Financial Advisors's Eli Lilly position peaked at $2.87M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Laraway Financial Advisors's 13F filing for Q1 2026, filed 14 May 2026.